| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/18/2001 | US6331612 Bone morphogenic protein-16 (BMP-16) compositions |
| 12/18/2001 | US6331571 Methods of treating and preventing attention deficit disorders |
| 12/18/2001 | US6331565 Inhibit virus dna replication and antigen expression |
| 12/18/2001 | US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors |
| 12/18/2001 | US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | US6331533 Administering to cat therapeutically effective amount of bisphosphonate or pharmaceutically acceptable salt thereof to treat feline dental resorptive lesions |
| 12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
| 12/18/2001 | US6331298 Wound healing and treatment of fibrotic disorders |
| 12/18/2001 | CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process |
| 12/18/2001 | CA2202484C Use of indole derivatives for the treatment of various diseases |
| 12/18/2001 | CA2178161C Indole derivatives |
| 12/13/2001 | WO2001094612A2 Method for identifying medically valuable active substances |
| 12/13/2001 | WO2001094582A1 Novel g protein-coupled receptor protein and dna thereof |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001094381A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 12/13/2001 | WO2001094369A2 Heterocycle derivatives and methods of use for treating anthrax infection |
| 12/13/2001 | WO2001094368A1 2-aminocarbonyl-9h-purine derivatives |
| 12/13/2001 | WO2001094351A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/13/2001 | WO2001094347A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | WO2001094346A1 1,3,8-TRIAZA-SPIRO'4,5!DECAN-4-ONE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS |
| 12/13/2001 | WO2001094345A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 12/13/2001 | WO2001094325A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | WO2001094307A1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 12/13/2001 | WO2001093904A1 Method of treating gastrointestinal diseases associated with species of genus clostridium |
| 12/13/2001 | WO2001093881A1 Immunological substance containing enteroabsorbable anti-inflammatory factor and application thereof |
| 12/13/2001 | WO2001093879A1 Biologically active agents and drugs |
| 12/13/2001 | WO2001093867A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | WO2001093856A1 Medical composition kit for treating lesioned abnormal tissue |
| 12/13/2001 | WO2001093849A2 Treatment of gastroesophageal reflux disease using piperidine derivatives |
| 12/13/2001 | WO2001093836A2 Encapsulation of polynucleotides and drugs into targeted liposomes |
| 12/13/2001 | WO2001093834A1 Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste |
| 12/13/2001 | WO2001093683A1 Treating smooth muscle hyperactivity with (r)-oxybutynin and (r)- desethyloxybutynin |
| 12/13/2001 | WO2001045735A3 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 12/13/2001 | WO2001045637A3 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides |
| 12/13/2001 | WO2001044228A3 Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses |
| 12/13/2001 | WO2001044200A3 Selective neurokinin antagonists |
| 12/13/2001 | WO2001041701A3 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 12/13/2001 | WO2001035899A3 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 12/13/2001 | WO2001026682A3 Modified plant viruses and methods of use thereof |
| 12/13/2001 | WO2001025219A3 Piperazine compounds |
| 12/13/2001 | WO2001021008A3 Method for increasing pet activity |
| 12/13/2001 | WO2001019362A3 Formulations for treating or preventing mucositis |
| 12/13/2001 | US20010051659 Non-fermented osmotic laxative and method for treating and preventing colorectal cancers |
| 12/13/2001 | US20010051611 Supplying protein, antibodies, ribozymes |
| 12/13/2001 | US20010051604 Mixture containing stabilizers, sodium chloride, buffer and surfactants |
| 12/13/2001 | EP1143806A3 Method for increasing pet activity |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2411542A1 Encapsulation of polynucleotides and drugs into targeted liposomes |
| 12/13/2001 | CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/13/2001 | CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409123A1 Heterocycle derivatives and methods of use |
| 12/13/2001 | CA2409015A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/13/2001 | CA2408670A1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 12/13/2001 | CA2378754A1 Treating smooth muscle hyperactivity with (r)-oxybutynin and (r)-deseth yloxybutynin |
| 12/12/2001 | EP1162196A1 Fused-ring compounds and use thereof as drugs |
| 12/12/2001 | EP1161447A1 50 human secreted proteins |
| 12/12/2001 | EP1161434A1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 12/12/2001 | EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 12/12/2001 | EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors |
| 12/12/2001 | EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 12/12/2001 | EP1161410A1 Retinoid antagonists and use thereof |
| 12/12/2001 | EP1161266A1 Matriptase, a serine protease and its applications |
| 12/12/2001 | EP1161251A2 Use of a composition comprising klebsiella pneumoniae proteoglycans, and bacterial ribosomes or ribosomal rna's for treating and/or preventing periodontal diseases |
| 12/12/2001 | EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/12/2001 | EP1161237A1 Protease inhibitors |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/12/2001 | EP1161153A1 Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 12/12/2001 | EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/12/2001 | EP0828502B1 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
| 12/12/2001 | EP0730465B1 Use of angiotensin iii and analogs thereof in tissue repair |
| 12/12/2001 | EP0666758B1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 12/12/2001 | CN1326462A Betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 12/12/2001 | CN1326458A CRF receptor antagonists and methods relating thereto |
| 12/12/2001 | CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors |
| 12/12/2001 | CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
| 12/12/2001 | CN1326455A Improved chemical process and pharmaceutical formulation |
| 12/12/2001 | CN1326453A Novel poyrimidine derivatives and process for preparation thereof |
| 12/12/2001 | CN1326449A Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2, 4-thiazolidinedione |
| 12/12/2001 | CN1326443A Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors |
| 12/12/2001 | CN1326353A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 12/12/2001 | CN1326339A Controlled release bead, method of producing the same and multiple unit formulation comprising it |
| 12/12/2001 | CN1326322A Method for supplying bioavailable methionine to cow |
| 12/12/2001 | CN1325718A Freeze dried compound queen bee powder |
| 12/12/2001 | CN1325714A Medicine for treating colitis |
| 12/12/2001 | CN1325709A Capsule for removing heat from liver and detoxicating and its preparing process |
| 12/12/2001 | CN1325706A Liquid medicine for baby to invigorate function of spleen and promote secretion of body fluid |
| 12/12/2001 | CN1325703A Health-care rhubarb composition |
| 12/12/2001 | CN1325701A Composite liquid medicine 'Aile' for treating deficiency of viral function and essence of kidney and night sweating |
| 12/12/2001 | CN1325687A Medicine for treating gastric ulcer and duodenal ulcer |
| 12/12/2001 | CN1076021C L-2',3'-dideoxy nucleoside analogs as antihepatitis B (HBV) and anti-HIV agents |
| 12/12/2001 | CN1076020C Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation method and compositions |
| 12/12/2001 | CN1075950C Traditional Chinese medicine for treating gastropathy |
| 12/11/2001 | US6329526 Cycloalkyl substituted imidazoles |
| 12/11/2001 | US6329511 Humanized mouse af2 immunoglobulin having specific amino acid sequences; treatment of autoimmune diseases |